Development of a Machine Learning Model Using Electronic Health Record Data to Identify Antibiotic Use Among Hospitalized Patients.


Journal

JAMA network open
ISSN: 2574-3805
Titre abrégé: JAMA Netw Open
Pays: United States
ID NLM: 101729235

Informations de publication

Date de publication:
01 03 2021
Historique:
entrez: 29 3 2021
pubmed: 30 3 2021
medline: 9 6 2021
Statut: epublish

Résumé

Comparisons of antimicrobial use among hospitals are difficult to interpret owing to variations in patient case mix. Risk-adjustment strategies incorporating larger numbers of variables haves been proposed as a method to improve comparisons for antimicrobial stewardship assessments. To evaluate whether variables of varying complexity and feasibility of measurement, derived retrospectively from the electronic health records, accurately identify inpatient antimicrobial use. Retrospective cohort study, using a 2-stage random forests machine learning modeling analysis of electronic health record data. Data were split into training and testing sets to measure model performance using area under the curve and absolute error. All adult and pediatric inpatient encounters from October 1, 2015, to September 30, 2017, at 2 community hospitals and 1 academic medical center in the Duke University Health System were analyzed. A total of 204 candidate variables were categorized into 4 tiers based on feasibility of measurement from the electronic health records. Antimicrobial exposure was measured at the encounter level in 2 ways: binary (ever or never) and number of days of therapy. Analyses were stratified by age (pediatric or adult), unit type, and antibiotic group. The data set included 170 294 encounters and 204 candidate variables from 3 hospitals during the 3-year study period. Antimicrobial exposure occurred in 80 190 encounters (47%); 64 998 (38%) received 1 to 6 days of therapy, and 15 192 (9%) received 7 or more days of therapy. Two-stage models identified antimicrobial use with high fidelity (mean area under the curve, 0.85; mean absolute error, 1.0 days of therapy). Addition of more complex variables increased accuracy, with largest improvements occurring with inclusion of diagnosis information. Accuracy varied based on location and antibiotic group. Models underestimated the number of days of therapy of encounters with long lengths of stay. Models using variables derived from electronic health records identified antimicrobial exposure accurately. Future risk-adjustment strategies incorporating encounter-level information may make comparisons of antimicrobial use more meaningful for hospital antimicrobial stewardship assessments.

Identifiants

pubmed: 33779743
pii: 2777837
doi: 10.1001/jamanetworkopen.2021.3460
pmc: PMC8008288
doi:

Substances chimiques

Anti-Bacterial Agents 0

Types de publication

Journal Article Multicenter Study Research Support, U.S. Gov't, P.H.S.

Langues

eng

Sous-ensembles de citation

IM

Pagination

e213460

Références

Clin Infect Dis. 2016 Nov 15;63(10):1273-1280
pubmed: 27694483
Clin Infect Dis. 2018 Nov 13;67(11):1686-1687
pubmed: 29688288
Clin Infect Dis. 2011 Dec;53(11):1100-10
pubmed: 21998281
BMJ. 2019 Jan 16;364:k5092
pubmed: 30651273
Clin Infect Dis. 2020 Aug 05;:
pubmed: 32756970
Infect Dis Clin North Am. 2014 Jun;28(2):195-214
pubmed: 24857388
Clin Infect Dis. 2018 Jul 2;67(2):179-185
pubmed: 29409000
Clin Infect Dis. 2018 Nov 13;67(11):1677-1685
pubmed: 29688279
Clin Infect Dis. 2014 Feb;58(3):401-6
pubmed: 24162744
Clin Infect Dis. 2020 Dec 17;71(10):e702-e709
pubmed: 32215655
J Antimicrob Chemother. 2017 Feb;72(2):554-563
pubmed: 27856724

Auteurs

Rebekah W Moehring (RW)

Duke Center for Antimicrobial Stewardship and Infection Prevention, Duke University Medical Center, Durham, North Carolina.

Matthew Phelan (M)

Duke Clinical Research Institute, Durham, North Carolina.
Department of Biostatistics and Bioinformatics, Duke University, Durham, North Carolina.

Eric Lofgren (E)

Paul G. Allen School for Global Animal Health, Washington State University, Pullman.

Alicia Nelson (A)

Duke Center for Antimicrobial Stewardship and Infection Prevention, Duke University Medical Center, Durham, North Carolina.

Elizabeth Dodds Ashley (E)

Duke Center for Antimicrobial Stewardship and Infection Prevention, Duke University Medical Center, Durham, North Carolina.

Deverick J Anderson (DJ)

Duke Center for Antimicrobial Stewardship and Infection Prevention, Duke University Medical Center, Durham, North Carolina.

Benjamin A Goldstein (BA)

Duke Clinical Research Institute, Durham, North Carolina.
Department of Biostatistics and Bioinformatics, Duke University, Durham, North Carolina.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH